JPMorgan Chase & Co. Raises Molina Healthcare (NYSE:MOH) Price Target to $392.00

Molina Healthcare (NYSE:MOH) had its price target boosted by JPMorgan Chase & Co. from $367.00 to $392.00 in a research note issued to investors on Friday morning, Benzinga reports. The firm currently has an overweight rating on the stock.

A number of other analysts have also recently weighed in on the company. StockNews.com upgraded Molina Healthcare from a buy rating to a strong-buy rating in a research report on Thursday, October 12th. Bank of America upped their price target on Molina Healthcare from $340.00 to $350.00 in a research report on Thursday, July 27th. Stephens reiterated an equal weight rating and issued a $350.00 price target on shares of Molina Healthcare in a research report on Tuesday, October 3rd. Finally, Cantor Fitzgerald reiterated an overweight rating and issued a $359.00 price target on shares of Molina Healthcare in a research report on Thursday, September 14th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, six have assigned a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of Moderate Buy and an average target price of $348.45.

Molina Healthcare Stock Up 0.8 %

MOH opened at $356.28 on Friday. Molina Healthcare has a fifty-two week low of $256.19 and a fifty-two week high of $369.50. The business has a 50-day moving average of $340.05 and a 200-day moving average of $313.54. The company has a debt-to-equity ratio of 0.61, a current ratio of 1.47 and a quick ratio of 1.47. The company has a market capitalization of $20.77 billion, a PE ratio of 22.21, a price-to-earnings-growth ratio of 1.21 and a beta of 0.57.

Molina Healthcare (NYSE:MOH) last issued its quarterly earnings results on Wednesday, October 25th. The company reported $5.05 EPS for the quarter, topping the consensus estimate of $4.87 by $0.18. Molina Healthcare had a return on equity of 34.85% and a net margin of 2.80%. The company had revenue of $8.55 billion for the quarter, compared to the consensus estimate of $8.24 billion. During the same period in the previous year, the business posted $4.36 EPS. The company’s revenue for the quarter was up 7.8% on a year-over-year basis. Equities research analysts forecast that Molina Healthcare will post 20.83 EPS for the current fiscal year.

Insider Buying and Selling at Molina Healthcare

In other Molina Healthcare news, CAO Maurice Hebert sold 692 shares of the stock in a transaction dated Wednesday, September 13th. The stock was sold at an average price of $328.15, for a total value of $227,079.80. Following the transaction, the chief accounting officer now owns 8,528 shares of the company’s stock, valued at $2,798,463.20. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In other Molina Healthcare news, Director Steven J. Orlando sold 1,134 shares of the firm’s stock in a transaction that occurred on Monday, October 30th. The stock was sold at an average price of $325.96, for a total value of $369,638.64. Following the completion of the transaction, the director now directly owns 19,299 shares in the company, valued at $6,290,702.04. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CAO Maurice Hebert sold 692 shares of the firm’s stock in a transaction that occurred on Wednesday, September 13th. The shares were sold at an average price of $328.15, for a total value of $227,079.80. Following the completion of the transaction, the chief accounting officer now owns 8,528 shares of the company’s stock, valued at $2,798,463.20. The disclosure for this sale can be found here. Insiders own 1.10% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of the stock. Annis Gardner Whiting Capital Advisors LLC acquired a new stake in shares of Molina Healthcare in the third quarter valued at approximately $30,000. Coppell Advisory Solutions Corp. acquired a new stake in shares of Molina Healthcare in the fourth quarter valued at approximately $34,000. ST Germain D J Co. Inc. acquired a new stake in shares of Molina Healthcare in the second quarter valued at approximately $33,000. Brown Brothers Harriman & Co. acquired a new stake in shares of Molina Healthcare in the first quarter valued at approximately $40,000. Finally, EverSource Wealth Advisors LLC lifted its position in shares of Molina Healthcare by 2,950.0% in the first quarter. EverSource Wealth Advisors LLC now owns 122 shares of the company’s stock valued at $33,000 after buying an additional 118 shares during the last quarter. 98.11% of the stock is currently owned by institutional investors.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments, Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.